Therapy News and Research

RSS

Dramatic increase in antibiotic-resistant staph infections

Staph infections resistant to antibiotics, previously only associated with hospitalization or prior contact with the healthcare system, are now widespread in the community and coming home.

9 Mar 2006

Study supports guidelines for treatment of aortic regurgitation

Patients with leaky aortic heart valves appear to do better when the valves are replaced before significant symptoms develop, as recommended by the American College of Cardiology/American Heart Association guidelines, according to a new study in the Journal of the American College of Cardiology.

9 Mar 2006

Aspirin is beneficial in a wide range of men for protection against heart disease

Taking aspirin to prevent coronary heart disease is beneficial and cost-effective for a wider range of men than is often recognized, a study from the University of North Carolina at Chapel Hill has found.

9 Mar 2006

Antiretroviral therapy (ART) should be strongly considered in the management of infants infected with HIV

Antiretroviral therapy (ART) for infants born with HIV infection may be most effective when given in their first five months of life, according to a study published in the April 1 issue of The Journal of Infectious Diseases.

9 Mar 2006

Metabolic switch required for cellular adaptation to hypoxia

Two new studies in the March Cell Metabolism reveal a survival mechanism by which cells adapt to oxygen starvation by ratcheting down their demand.

9 Mar 2006

Scientists fight leukaemia with 'natural killer' cells

Scientists at the University of the West of England and the Bone Marrow Transplant Unit at the Bristol Children's Hospital have just won funding for a two-year project aimed at improving the outcome of bone marrow stem-cell transplants in young leukaemia patients.

8 Mar 2006

Swedish theory suggests treatment for Avian Influenza Infection

Chemotherapy for a disorder of the immune system may - at least in theory - be effective against severe human avian influenza infection, this suggest scientists at the Karolinska Institutet.

8 Mar 2006

Is there any role for thalidomide as a monotherapy in the management of metastatic renal cell carcinoma?

Thalidomide remains an enigma in the treatment of metastatic renal cell carcinoma (RCC). Initial clinical trials suggested a benefit, but more recently, subsequent randomized trials studying thalidomide in combination with other agents such as interferon have demonstrated no added benefit.

8 Mar 2006

Clinical implication of routine stone culture in percutaneous nephrolithotomy - A prospective study

If you have a patient with a staghorn stone and the preoperative urine culture is sterile, does that mean that the stone is likewise sterile? The answer is No.

7 Mar 2006

Will the FDA rise to the occasion and admit their natalizumab mistake?

When Anita Louise Smith enrolled in an experimental drug trial in 2002 in Colorado, she had a diagnosis of multiple sclerosis but no symptoms and was looking to reduce the chances of being ravaged by the disease.

7 Mar 2006

Gene therapy approach used in creating new arteries for older patients does not appear to cause cancer

"This result is an encouraging step along the road to new tissues for patients to replace those that have failed or have been destroyed due to trauma or disease," she said.

7 Mar 2006

Study to explore whether hormone therapy in women during menopause protects against atherosclerosis

Researchers in The Department of Obstetrics, Gynecology & Reproductive Sciences at Yale have launched the Kronos Early Estrogen Prevention Study (KEEPS), which will further understanding of the possible beneficial effects on the heart and arteries and/or quality of life in recently menopausal women.

7 Mar 2006

Extensive study of natalizumab

Scientists have completed an extensive study of more than 3,000 patients who received a promising anti-inflammatory drug, natalizumab, that was linked to three cases of a serious brain infection in large clinical trials halted in early 2005.

7 Mar 2006

Photodynamic therapy lighting the way for medical treatments

For the millions of people who suffer from acne, sun damage or even worse, skin cancer, there is a light of hope - photodynamic therapy or PDT.

6 Mar 2006

Data from Novogen inflammatory bowel disease drug Phase I clinical trial shows promise

A recently completed Phase 1 clinical trial of an investigational drug to treat inflammatory bowel disease has demonstrated rapid absorption indicating potential for development as an oral therapy.

6 Mar 2006

Topical therapies show promise for Psoriasis

Psoriasis, a chronic skin condition characterized by thick, red, scaly patches that itch and bleed, not only makes the activities of daily life difficult, but also can affect a person's emotional well being.

6 Mar 2006

Individualized treatment options for rosacea

Many individuals who are struggling with redness, pimples and visible blood vessels on their face may incorrectly diagnose their condition as acne, sunburn or sensitive skin.

6 Mar 2006

FDA grants priority review for Revlimid

Celgene Corporation announced that the U.S. Food and Drug Administration (FDA) has granted a Priority Review designation to its Supplemental New Drug Application (sNDA) for REVLIMID (lenalidomide) for the treatment of relapsed or refractory multiple myeloma.

6 Mar 2006

Study shows new atopic dermatitis therapy significantly delays onset of flares

Stiefel Laboratories, the world's largest independent pharmaceutical company specializing in dermatology, announced that a recent study shows MimyX Cream extends the remission period of atopic dermatitis (AD) by 48 percent when used in conjunction with an emollient compared to emollient alone.

6 Mar 2006

Study shows Differin Gel works well in combination with systemic or other topical agents

Findings from the M.O.R.E. (Measuring Outcomes in A Real World Experience) Trial presented at the 64th annual meeting of the American Academy of Dermatology (AAD) show that Differin Gel 0.1% is a topical retinoid preparation that, when combined with other acne products, dramatically improves the efficacy of an acne regimen.

6 Mar 2006

Therapy News and Research

Dramatic increase in antibiotic-resistant staph infections

Study supports guidelines for treatment of aortic regurgitation

Aspirin is beneficial in a wide range of men for protection against heart disease

Antiretroviral therapy (ART) should be strongly considered in the management of infants infected with HIV

Metabolic switch required for cellular adaptation to hypoxia

Scientists fight leukaemia with 'natural killer' cells

Swedish theory suggests treatment for Avian Influenza Infection

Is there any role for thalidomide as a monotherapy in the management of metastatic renal cell carcinoma?

Clinical implication of routine stone culture in percutaneous nephrolithotomy - A prospective study

Will the FDA rise to the occasion and admit their natalizumab mistake?

Gene therapy approach used in creating new arteries for older patients does not appear to cause cancer

Study to explore whether hormone therapy in women during menopause protects against atherosclerosis

Extensive study of natalizumab

Photodynamic therapy lighting the way for medical treatments

Data from Novogen inflammatory bowel disease drug Phase I clinical trial shows promise

Topical therapies show promise for Psoriasis

Individualized treatment options for rosacea

FDA grants priority review for Revlimid

Study shows new atopic dermatitis therapy significantly delays onset of flares

Study shows Differin Gel works well in combination with systemic or other topical agents

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News